首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
Patent term extensions for human drugs under the US Hatch-Waxman Act
被引:2
|
作者
:
Boone, Jeffrey S.
论文数:
0
引用数:
0
h-index:
0
机构:
Covidien, Intellectual Property, 675 McDonnell Blvd, Hazelwood, MO 63042 USA
Covidien, Intellectual Property, 675 McDonnell Blvd, Hazelwood, MO 63042 USA
Boone, Jeffrey S.
[
1
]
机构
:
[1]
Covidien, Intellectual Property, 675 McDonnell Blvd, Hazelwood, MO 63042 USA
来源
:
JOURNAL OF INTELLECTUAL PROPERTY LAW & PRACTICE
|
2009年
/ 4卷
/ 09期
关键词
:
D O I
:
10.1093/jiplp/jpp110
中图分类号
:
D9 [法律];
DF [法律];
学科分类号
:
0301 ;
摘要
:
[No abstract available]
引用
收藏
页码:658 / 664
页数:7
相关论文
共 50 条
[21]
The Hatch-Waxman Act and the declaratory judgment action: Constitutional and practical implications
Gu, HH
论文数:
0
引用数:
0
h-index:
0
机构:
Rutgers State Univ, Sch Law, Newark, NJ 07102 USA
Rutgers State Univ, Sch Law, Newark, NJ 07102 USA
Gu, HH
[J].
RUTGERS LAW REVIEW,
2005,
57
(02)
: 771
-
802
[22]
Overview of the Hatch-Waxman Act and its impact on the drug development process
Mossinghoff, GJ
论文数:
0
引用数:
0
h-index:
0
机构:
Oblon Spivak McClelland Maier & Neustadt PC, Arlington, VA USA
Oblon Spivak McClelland Maier & Neustadt PC, Arlington, VA USA
Mossinghoff, GJ
[J].
FOOD AND DRUG LAW JOURNAL,
1999,
54
(02)
: 187
-
194
[23]
Rational Antitrust Policy and Reverse Payment Settlements in Hatch-Waxman Patent Litigation
Opderbeck, David W.
论文数:
0
引用数:
0
h-index:
0
机构:
Seton Hall Univ, Sch Law, S Orange, NJ 07079 USA
Seton Hall Univ, Sch Law, S Orange, NJ 07079 USA
Opderbeck, David W.
[J].
GEORGETOWN LAW JOURNAL,
2010,
98
(05)
: 1303
-
1348
[24]
DELAYED ACCESS TO GENERIC MEDICINE: A COMMENT ON THE HATCH-WAXMAN ACT AND THE "APPROVAL BOTTLENECK"
Patel, Ankur N.
论文数:
0
引用数:
0
h-index:
0
机构:
Fordham Univ, Sch Law, Bronx, NY 10458 USA
Fordham Univ, Sch Law, Bronx, NY 10458 USA
Patel, Ankur N.
[J].
FORDHAM LAW REVIEW,
2009,
78
(02)
: 1075
-
1115
[25]
Litigation under the Hatch Waxman Act.
Stack, S
论文数:
0
引用数:
0
h-index:
0
机构:
Dechert LLP, Philadelphia, PA 19103 USA
Dechert LLP, Philadelphia, PA 19103 USA
Stack, S
[J].
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY,
2004,
228
: U397
-
U397
[26]
The Balance Between Innovation and Competition: The Hatch-Waxman Act, the 2003 Amendments, and Beyond
Kelly, Colleen
论文数:
0
引用数:
0
h-index:
0
机构:
Harvard Univ, Sch Law, Cambridge, MA 02138 USA
Covington & Burling LLP, Washington, DC USA
Harvard Univ, Sch Law, Cambridge, MA 02138 USA
Kelly, Colleen
[J].
FOOD AND DRUG LAW JOURNAL,
2011,
66
(03)
: 417
-
478
[27]
Changes to the Hatch-Waxman Act following the "Medicare Prescription Drug, Improvement and Modernization Act of 2003"
Marenberg, BJ
论文数:
0
引用数:
0
h-index:
0
Marenberg, BJ
[J].
BIOTECHNOLOGY LAW REPORT,
2004,
23
(03)
: 277
-
280
[28]
Expanding the scope of the Hatch-Waxman Act's patent carve-out exception to the identical drug labeling requirement: Closing the patent litigation loophole
Dohm, Julie
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Penn, Sch Law, Philadelphia, PA 19104 USA
Univ Penn, Sch Law, Philadelphia, PA 19104 USA
Dohm, Julie
[J].
UNIVERSITY OF PENNSYLVANIA LAW REVIEW,
2007,
156
(01)
: 151
-
196
[29]
US Supreme Court could reshape Hatch-Waxman's same labeling requirement
Sullivan, Clark G.
论文数:
0
引用数:
0
h-index:
0
机构:
Arnall Golden Gregory, Atlanta, GA 30363 USA
Arnall Golden Gregory, Atlanta, GA 30363 USA
Sullivan, Clark G.
[J].
FUTURE MEDICINAL CHEMISTRY,
2012,
4
(01)
: 7
-
8
[30]
A brief history of 180-day exclusivity under the Hatch-Waxman Amendments to the Federal Food, Drug, and Cosmetic Act
Lietzan, EK
论文数:
0
引用数:
0
h-index:
0
机构:
PhRMA, Washington, DC USA
PhRMA, Washington, DC USA
Lietzan, EK
[J].
FOOD AND DRUG LAW JOURNAL,
2004,
59
(02)
: 287
-
+
←
1
2
3
4
5
→